HOME >> MEDICINE >> NEWS
Revlimid data presented at ASCO stands to change the way physicians treat multiple myeloma

Tampa, FL -- (June 4, 2007) -- Findings from a Phase III study by the Eastern Cooperative Oncology Group (ECOG 4A03) were presented yesterday at the American Society of Clinical Oncology (ASCO) meeting in Chicago and demonstrate the benefits of using Revlimid (lenalidomide) with reduced doses of the steroid dexamethasone. Based upon these data, the U.S. Myeloma Forum, a committee of leading myeloma researchers including Dr. Mohamad Hussein, Clinical Director of the Malignant Hematology Division & Head of Myeloma Section at the H. Lee Moffitt Cancer Center & Research Institute, met to discuss and develop plans for further medical studies.

At the meeting, which was organized by the International Myeloma Foundation, the researchers approved plans to study novel therapeutic options for newly diagnosed myeloma patients, without first offering bone marrow (stem cell) transplants that have been the standard of care up until now.

"Because of the strong one-year survival data seen in the ECOG trial, we think there is a need to continue to evaluate novel treatment options. The development of new therapeutic agents which are very effective combined with the model of changing myeloma into a chronic disease process is making us rethink our traditional treatment paradigm, where therapy is decided on if or if not the patient qualifies for high dose therapy and bone marrow (stem cell) transplant. With the current knowledge of disease biology and new effective therapy with a large safety margin, the myeloma community is able to reorganize the role of transplant in patients with multiple myeloma," said Dr. Hussein, "Stem cell harvest and saving after inducing response/remission should be the standard in all patients not receiving transplant to allow for this option as our knowledge advances. Oral therapies as first-line treatment would be a major advance in how we care for myeloma patients."

About ECOG 4A03 Trial

Top line findings from
'"/>

Contact: Michelle Foley
michelle.foley@moffitt.org
813-745-1505
Weber Shandwick Worldwide
4-Jun-2007


Page: 1 2

Related medicine news :

1. Ulcerative colitis remission rates from long-term safety study of LIALDA presented at DDW
2. Data on new vaccine for prostate cancer to be presented
3. Clinical trial data for Perforomist Inhalation Solution presented at International ATS Conference
4. Epidemiology of TB: Updates from CDC studies to be presented at ATS 2007
5. Clinical trial data for Perforomist Inhalation Solution to be presented at ATS on May 20, 2007
6. Mayo Clinic research in cardiovascular disease presented at Experimental Biology 2007
7. AACR awards minority and other underrepresented scientists
8. Oral Biology Research Award presented to Russell
9. Craniofacial Biology Award presented to Vargervik
10. Clinical study results using Aldagens product to isolate cord blood stem cells presented at ASH
11. Lisdexamfetamine dimesylate in ADHD phase 3 data presented

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... ... August 31, 2020 , ... Smile ... dental groups in the United States, today announced the grand opening of another ... , Patients will enjoy convenient hours, a comfortable office, and full-service care ...
(Date:8/31/2020)... ... 2020 , ... Dr. Chang has over 20 years of ... developmental disabilities, as well as supporting staff in caring for patients and families. ... and staff development. She joined the company in 2015 as Chief of Clinical ...
(Date:8/28/2020)... ... August 28, 2020 , ... WHAT , Hespiro™ ... patients with respiratory conditions, including COVID-19, while reducing the need for scarce mechanical ... captures exhaled gas and scrubs it free of carbon dioxide in a completely ...
(Date:8/28/2020)... , ... August 28, 2020 , ... ... in advising Adventist Health on its investment in Synchronous Health, a tech-enabled behavioral ... that combines the strength of human empathy with artificial intelligence (AI) to increase ...
(Date:8/27/2020)... ... 2020 , ... Evolution Labs announced today that Florida Virtual ... Suite360:Mental Health and Prevention, a program developed to help students navigate a range ... Florida schools and districts must provide their students with preventative lessons after recent ...
Breaking Medicine News(10 mins):
(Date:8/27/2020)... , ... August 27, 2020 , ... The flu season is right round the corner ... well equipped with all the necessary measures before it begins to harbor its effects on ... and it is leaving a huge impact on our lives. Hence it has become even ...
(Date:8/26/2020)... , ... August 26, 2020 , ... ... Chiropractic Care Helps Sports Injuries. The infographic breaks down ways that chiropractors can ... healthier recovery. , According to ScripHessco “Athletes have an unusual amount of pressure ...
(Date:8/26/2020)... , ... August 26, 2020 , ... As the U.S. ... the daily routine for preventing the Coronavirus. Wear a mask, keep your distance, wash ... advocate Dr. Denis Burkitt said it best in 1977, “How much better it is ...
Breaking Medicine Technology:
Cached News: